Skip to content
TrustList
Vesalius Biocapital III logo
Venture capital firm

Vesalius Biocapital III

Vesalius Biocapital III

Vesalius Biocapital III cover

About Vesalius Biocapital III

Vesalius Biocapital is a European life sciences venture capital investor The active fund Vesalius Biocapital III had a final closing in May 2019 with € 120 million in commitments

We are investing in appealing, later-stage companies in drug development, medical devices & diagnostics and eHealth / mHealth, predominantly in Europe Our portfolio companies address unmet medical & market needs and operate on the basis of strong intellectual property protection

Vintage 2017 - € 120 million assets under management In investment mode

Ask TrustList to introduce you to Vesalius Biocapital III

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA — Google Privacy Policy and Terms apply.

Reviews

Write the first review of Vesalius Biocapital III

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Vesalius Biocapital III.

Vesalius Biocapital III alternatives

Similar listings buyers compare against this one.